THE PRESENT INVENTION IS DIRECTED TO COMPOUNDS OF FORMULA I-II AND PHARMACEUTICALLY ACCEPTABLE TAUTOMERS, SALTS, OR STEREOISOMERS THEREOF WHICH ARE INHIBITORS OF SYK AND/OR JAK KINASE. THE PRESENT INVENTION IS ALSO DIRECTED TO INTERMEDIATES USED IN MAKING SUCH COMPOUNDS, THE PREPARATION OF SUCH A COMPOUND, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH A COMPOUND, METHODS OF INHIBITION SYK AND/OR JAK KINASE ACTIVITY, METHODS OF INHIBITION THE PLATELET AGGREGATION, AND METHODS TO PREVENT OR TREAT A NUMBER OF CONDITIONS MEDIATED AT LEAST IN PART BY SYK AND/OR JAK KINASE ACTIVITY, SUCH AS CARDIOVASCULAR DISEASE, INFLAMMATORY DISEASE, AUTOIMMUNE DISEASE AND CELL PROLIFERATIVE DISORDER, THROMBOSIS, ALLERGY, ASTHMA, RHEUMATOID ARTHRITIS, LEUKEMIA, OR NON-HODGKIN’S LYMPHOMA. (NO SUITABLE FIGURE)
